CClinicalTrials.gg
CompletedNCT04233411Updated Jan 18, 2020

The Bioavailability of Mycoprotein

An interventional study of Mycoprotein ingestion in Availability of Mycoprotein, sponsored by University of Exeter. Completed at 1 site in United Kingdom. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-18.

Sponsored by University of Exeter · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Male
01

Study summary

To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.

02

Conditions studied

  • Availability of Mycoprotein
03

In context

Lead sponsor

University of Exeter is the lead sponsor of 138 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy and aged 18-40 y
  • BMI between 18 and 30

Exclusion criteria

Exclusion Criteria:

  • On medication
  • Family history of metabolic disease
  • Diagnosed with any metabolic or cardiovascular conditions
  • BMI \< 18 or > 30
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
12 participants (actual)

Study arms

  • Active comparator
    Milk

    Acute ingestion of 20 g milk protein

    Other: Mycoprotein ingestion

  • Experimental
    20g

    Acute ingestion of 20 g mycoprotein

    Other: Mycoprotein ingestion

  • Experimental
    40g

    Acute ingestion of 40 g mycoprotein

    Other: Mycoprotein ingestion

  • Experimental
    60g

    Acute ingestion of 60 g mycoprotein

    Other: Mycoprotein ingestion

  • Experimental
    80g

    Acute ingestion of 60 g mycoprotein

    Other: Mycoprotein ingestion

Interventions

  • OtherMycoprotein ingestion
06

What researchers measure

Primary outcomes

  1. Plasma total amino acid concentrations

    Time frame: 4 hours

07

Study locations

1 site
  • Sport & Health Sciences
    Exeter, Devon EX1 2LU, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04233411
Lead sponsor
University of Exeter
Responsible party
Sponsor
First posted
Jan 18, 2020
Start date
Jan 2016
Primary completion
Aug 2017
Completion
Jan 2018
Last update
Jan 18, 2020

Study contacts

Benjamin T Wall, PhD
principal investigator · University of Exeter, College of Life and Environmental Sciences

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion